Ashraf Amlani

958 total citations
20 papers, 697 citations indexed

About

Ashraf Amlani is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Ashraf Amlani has authored 20 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Public Health, Environmental and Occupational Health and 3 papers in Infectious Diseases. Recurrent topics in Ashraf Amlani's work include Opioid Use Disorder Treatment (11 papers), HIV, Drug Use, Sexual Risk (7 papers) and Substance Abuse Treatment and Outcomes (7 papers). Ashraf Amlani is often cited by papers focused on Opioid Use Disorder Treatment (11 papers), HIV, Drug Use, Sexual Risk (7 papers) and Substance Abuse Treatment and Outcomes (7 papers). Ashraf Amlani collaborates with scholars based in Canada, United Kingdom and United States. Ashraf Amlani's co-authors include Jane A. Buxton, Charlene Burmeister, Alissa Greer, Geoffrey McKee, Erica S. Tsang, Serena Luchenski, Bernie Pauly, Alice Mui, Raymond J. Andersen and David E. Williams and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Infectious Diseases and BMC Public Health.

In The Last Decade

Ashraf Amlani

20 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashraf Amlani Canada 15 413 393 120 101 82 20 697
Christy Sutherland Canada 16 378 0.9× 336 0.9× 161 1.3× 53 0.5× 65 0.8× 35 708
George Karandinos United States 8 395 1.0× 320 0.8× 63 0.5× 107 1.1× 123 1.5× 16 596
Fernando Montero United States 10 537 1.3× 373 0.9× 52 0.4× 204 2.0× 133 1.6× 14 833
David Frank United States 15 514 1.2× 503 1.3× 74 0.6× 38 0.4× 100 1.2× 35 769
Daniel Rosenblum Canada 11 512 1.2× 345 0.9× 40 0.3× 164 1.6× 210 2.6× 20 785
María Luisa Mittal United States 15 344 0.8× 418 1.1× 77 0.6× 48 0.5× 43 0.5× 33 542
Kristen Ochoa United States 8 269 0.7× 461 1.2× 86 0.7× 72 0.7× 43 0.5× 11 583
Isabelle Feroni France 11 318 0.8× 289 0.7× 86 0.7× 67 0.7× 41 0.5× 21 455
Sagar Kumar United States 10 208 0.5× 157 0.4× 121 1.0× 51 0.5× 58 0.7× 34 509
Allison M. Salmon Australia 15 408 1.0× 407 1.0× 158 1.3× 118 1.2× 24 0.3× 34 623

Countries citing papers authored by Ashraf Amlani

Since Specialization
Citations

This map shows the geographic impact of Ashraf Amlani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashraf Amlani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashraf Amlani more than expected).

Fields of papers citing papers by Ashraf Amlani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashraf Amlani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashraf Amlani. The network helps show where Ashraf Amlani may publish in the future.

Co-authorship network of co-authors of Ashraf Amlani

This figure shows the co-authorship network connecting the top 25 collaborators of Ashraf Amlani. A scholar is included among the top collaborators of Ashraf Amlani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashraf Amlani. Ashraf Amlani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mowat, A G, et al.. (2023). Rigid bronchoscopy: a consultant survey. Annals of The Royal College of Surgeons of England. 106(4). 377–384. 1 indexed citations
2.
Amlani, Ashraf, et al.. (2021). Ambulatory management of common ENT emergencies – what's the evidence?. The Journal of Laryngology & Otology. 135(3). 191–195. 2 indexed citations
3.
Buxton, Jane A., Ashraf Amlani, Margot Kuo, et al.. (2019). The British Columbia Drug Overdose and Alert Partnership: Interpreting and sharing timely illicit drug information to reduce harms. SHILAP Revista de lepidopterología. 4(1). 4–9. 16 indexed citations
4.
Greer, Alissa, Ashraf Amlani, Charlene Burmeister, et al.. (2019). Peer engagement barriers and enablers: insights from people who use drugs in British Columbia, Canada. Canadian Journal of Public Health. 110(2). 227–235. 37 indexed citations
5.
Voon, Pauline, et al.. (2018). Pain as a risk factor for substance use: a qualitative study of people who use drugs in British Columbia, Canada. Harm Reduction Journal. 15(1). 35–35. 40 indexed citations
6.
Greer, Alissa, Ashraf Amlani, Bernie Pauly, Charlene Burmeister, & Jane A. Buxton. (2018). Participant, peer and PEEP: considerations and strategies for involving people who have used illicit substances as assistants and advisors in research. BMC Public Health. 18(1). 834–834. 34 indexed citations
7.
8.
Amlani, Ashraf, et al.. (2016). Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia. Harm Reduction Journal. 13(1). 17–17. 28 indexed citations
9.
Otterstatter, Michael, et al.. (2016). Illicit drug overdose deaths resulting from income assistance payments: Analysis of the ‘check effect’ using daily mortality data. International Journal of Drug Policy. 33. 83–87. 31 indexed citations
10.
Luchenski, Serena, et al.. (2016). Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada. BMC Public Health. 16(1). 452–452. 83 indexed citations
11.
Amlani, Ashraf, et al.. (2016). Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey. Substance Abuse Treatment Prevention and Policy. 11(1). 3–3. 14 indexed citations
12.
13.
Tzemis, Despina, Ashraf Amlani, Darlene Taylor, et al.. (2015). Reorienting risk to resilience: street-involved youth perspectives on preventing the transition to injection drug use. BMC Public Health. 15(1). 800–800. 13 indexed citations
14.
Gardy, Jennifer L., Monika Naus, Ashraf Amlani, et al.. (2015). Whole-Genome Sequencing of Measles Virus Genotypes H1 and D8 During Outbreaks of Infection Following the 2010 Olympic Winter Games Reveals Viral Transmission Routes. The Journal of Infectious Diseases. 212(10). 1574–1578. 50 indexed citations
15.
Greer, Alissa, et al.. (2015). Drug quality assessment practices and communication of drug alerts among people who use drugs. International Journal of Drug Policy. 26(12). 1251–1257. 55 indexed citations
16.
McKee, Geoffrey, et al.. (2015). Illicit fentanyl: An emerging threat to people who use drugs in BC. 3 indexed citations
17.
Amlani, Ashraf, et al.. (2014). A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open. 2(3). E153–E161. 77 indexed citations
18.
Amlani, Ashraf, et al.. (2013). Using Magic to Influence Choice in the Absence of Visual Awareness. Journal of Vision. 13(9). 1133–1133. 5 indexed citations
19.
Li, Dehai, Gavin Carr, Yonghong Zhang, et al.. (2011). Turnagainolides A and B, Cyclic Depsipeptides Produced in Culture by a Bacillus sp.: Isolation, Structure Elucidation, and Synthesis. Journal of Natural Products. 74(5). 1093–1099. 41 indexed citations
20.
Williams, David E., Ashraf Amlani, Brian O. Patrick, et al.. (2010). Australin E Isolated from the Soft Coral Cladiella sp. Collected in Pohnpei Activates the Inositol 5-Phosphatase SHIP1. Australian Journal of Chemistry. 63(6). 895–900. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christy Sutherland Breakdown of academic impact, for papers by George Karandinos Breakdown of academic impact, for papers by Fernando Montero Breakdown of academic impact, for papers by David Frank Breakdown of academic impact, for papers by Daniel Rosenblum Breakdown of academic impact, for papers by María Luisa Mittal Breakdown of academic impact, for papers by Kristen Ochoa Breakdown of academic impact, for papers by Isabelle Feroni Breakdown of academic impact, for papers by Sagar Kumar Breakdown of academic impact, for papers by Allison M. Salmon
Rankless by CCL
2026